AtheroMed Expands Menlo Park Presence Following New Lease

The medical startup is responsible for a device that helps treat peripheral arterial disease.

Menlo Park, Calif.–Although in recent months the Bay Area has lost its hold on the title of best place to launch a startup, the tech and biotech communities by the Bay are still thriving.

A case in point would be the recent expansion completed by AtheroMed, a medical device startup located in Menlo Park. The biotech company was purchased by the Volcano Corp. back in 2014 for roughly $115 million; Volcano was then purchased by Philips in a deal worth $1.2 billion.

Menlo Business Park

Menlo Business Park

The company inked an agreement that will nearly double the amount of space it occupies at Menlo Business Park. Following the lease, AtheroMed will move from its 6,700 square feet at 1455 Adams Drive in Tarlton’s Menlo Labs campus, to a space totaling 10,000 square feet at 1530 O’Brien Drive. Both assets are controlled by a joint venture between Principal Real Estate Investors and Tarlton Properties. During the leasing process, the tenant worked with representation from JLL, while the landlord was advised by a Kidder Matthews team.

AtheroMed’s flagship product is the Phoenix Atherectomy System, which helps treat peripheral arterial disease by increasing blood flow through the opening of narrowed coronary arteries.

Menlo Business Park is located on a 50-acre lot in Menlo Park, Calif., and offers roughly 900,000 square feet of space across 18 buildings. The campus offers startups proximity to Stanford University and the Stanford Research Park, as well as to a number of the area’s main transit lines.

Image courtesy of Tarlton Properties